Literature DB >> 12131934

Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients.

Joaquín Peña1, Eduardo Mora, José Cardozo, Omaira Molina, Cecilia Montiel.   

Abstract

In order to compare and contrast the efficacy of haloperidol, carbamazepine, and valproic acid in the treatment of Sydenham's chorea a prospective study including 18 cases of this disorder was undertaken. Age of patients ranged from 7 to 15 years. Ten children were female and 8 were male. All but one had generalized, either symmetric or asymmetric chorea. The patients were divided in three equal groups, and were given a standardized dose of each of the drugs built-up over a week. Following therapy, the six children receiving valproic acid showed remarkable improvement, without side effects. Five patients receiving carbamazepine showed improvement without side effects. Only three of the patients that received haloperidol improved. In the 4 cases that did not show clinical improvement after one week of treatment, therapy with valproic acid led to disappearance of the symptoms in a lapse that ranged from 4 to 7 days. Recurrence related to discontinuation of treatment was observed in two patients. In view of the present results we recommend valproic acid as the first choice drug to treat Sydenham chorea.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131934     DOI: 10.1590/s0004-282x2002000300006

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  19 in total

Review 1.  Prescribing for people with acute rheumatic fever.

Authors:  Anna P Ralph; Sara Noonan; Claire Boardman; Catherine Halkon; Bart J Currie
Journal:  Aust Prescr       Date:  2017-04-03

2.  Chorea mollis: long-term follow-up of an infantile case.

Authors:  Umberto Balottin; Elena Calcaterra; Fabio Zambonin; Pierangelo Veggiotti; Chiara Luoni; Cristiano Termine
Journal:  Neurol Sci       Date:  2011-09-24       Impact factor: 3.307

Review 3.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

4.  An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

Authors:  Kathleen G Walker; Jo M Wilmshurst
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

5.  Paroxysmal non-kinesigenic dyskinesia, post-streptococcal syndromes and psychogenic movement disorders: a diagnostic challenge.

Authors:  Elena Peila; Paolo Mortara; Alessandro Cicerale; Lorenzo Pinessi
Journal:  BMJ Case Rep       Date:  2015-03-20

6.  The pattern of acute rheumatic fever in children: Experience at the children's hospital, Riyadh, Saudi Arabia.

Authors:  Mansour Al Qurashi
Journal:  J Saudi Heart Assoc       Date:  2009-10

Review 7.  An Update on the Treatment of Chorea.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Curr Treat Options Neurol       Date:  2018-09-25       Impact factor: 3.598

8.  Gluten Ataxia and Post-Streptococcal Central Nervous System Syndromes: Emerging Immune-mediated Disorders of the Central Nervous System?

Authors:  Adrian Wills; Russell Dale; Gavin Giovannoni
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.972

9.  Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management.

Authors:  Antonio Siniscalchi; Luca Gallelli; Angelo Labate; Giovanni Malferrari; Caterina Palleria; Giovambattista De Sarro
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

10.  Sydenham Chorea in Children.

Authors:  Lori C. Jordan; Harvey S. Singer
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.